Abstract: The present application provides a display box and a display device. The display box includes a box body and a first support plate detachably connected with the box body. The first support plate is one of multiple first support plates with different sizes, and the multiple first support plates are selectively detachably connected with the box body for supporting flexible screens with different bending radii.

Abstract: The present invention provides compositions or formulations comprising the combination of a compound of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione or a salt thereof or hydrate of the foregoing, and a cyclodextrin; or in further combination with an excipient comprising L-Arginine or other additives, wherein the compositions or formulations increases water solubility and oral bioavailability of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione and its related compounds. The method of making or using the compositions or formulations is also disclosed. Such compositions or formulations may be used in treatment of certain diseases including asthma through inhibition of matrix metalloproteinase-12.

Abstract: The present invention provides for a stabilized biodegradable polymeric composition useful as a controlled release delivery system for peptide agents. The compositions of the present invention comprise a) a beneficial salt of a luteinizing hormone releasing hormone (LHRH) analogue formed with a strong acid that minimizes or prevents the interaction/reaction between the LHRH and the polymer in an organic solution; b) a biodegradable polymer; c) a pharmaceutically acceptable organic solvent; and d) optionally one or more excipients. The present invention also relates to a method of manufacturing and a method of use thereof.

Abstract: Embodiments of the present invention provide a terminal control method and apparatus, and a terminal. The method includes: when a screen of a terminal is switched from a screen-on state to a screen-off state, detecting whether an enabling condition of a power saving mode is satisfied; and if the enabling condition of the power saving mode is satisfied, performing a power saving operation, where the power saving operation is used to reduce power consumption that occurs when an application program in the terminal runs in a background. In the embodiments of the present invention, power consumption in a screen-off state is reduced as much as possible without affecting normal use of a user.

Abstract: This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Abstract: The invention provides a bedding structure used for supporting back and neck, which is composed of an adjustment base, a plurality of extension arms and a plurality of support plates. It may only use a rotating motor to drive the mechanical deformation of a lying structure to form an ergonomically sitting structure or a structure between lying and sitting.

Abstract: The present invention provides compositions or formulations comprising the combination of a compound of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione or a salt thereof or hydrate of the foregoing, and a cyclodextrin; or in further combination with an excipient comprising L-Arginine or other additives, wherein the compositions or formulations increases water solubility and oral bioavailability of 5-[3-(4-benzyloxyphenylthio)-fur-2-yl]-imidazolidin-2,4-dione and its related compounds. The method of making or using the compositions or formulations is also disclosed. Such compositions or formulations may be used in treatment of certain diseases including asthma through inhibition of matrix metalloproteinase-12.

Abstract: This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Abstract: Disclosed is a reference voltage circuit with low temperature drift, including a first voltage unit, a second voltage unit and a K times' amplification unit. The first voltage unit is configured to generate a first voltage, with a first end thereof being grounded. The K times' amplification unit is configured to amplify the first voltage by K times, with a first end thereof being connected to a second end of the first voltage unit, and with a second end thereof being connected to a first end of the second voltage unit, wherein K is a constant greater than zero. The second voltage unit is configured to generate a second voltage, with the first end thereof being connected to a current source circuit, and a second end thereof being connected to a third end of the first voltage unit to serve as an output end of a reference voltage (VREF).

Abstract: A method and device for controlling in-plane interference of a liquid crystal touch screen and a display system are provided. By detecting a current image of a display panel of the liquid crystal touch screen in real time, and when the image that causes the in-plane interference of the liquid crystal touch screen is detected, inverting original polarities of data voltages input to at least a portion of data lines of the display panel, so that change directions of coupled voltages of adjacent two of the data lines with respect to a common electrode are opposite to each other, solving problems of in-plane interference for the liquid crystal touch screen.

Abstract: The application relates to an electrotherapeutic device for inducing thrombosis, which includes a power source and a guide wire portion.

Abstract: An electric roasting machine includes an outer housing, a heating device accommodated in the outer housing, and an inner housing between the outer housing and the heating device. A heat insulating cavity is formed between the inner housing and the heating device. A heat dissipating passage is formed between the outer housing and the inner housing.

Abstract: An electric roasting machine includes a housing defining a cavity having an upper opening, a heating device installed in the cavity, and a grill located at the opening of the cavity. The grill includes a carrying part extending into the cavity and located in a region covered by thermal radiation of the heating device.

Abstract: The present invention provides for a stabilized biodegradable polymeric composition useful as a controlled release delivery system for peptide agents. The compositions of the present invention comprise a) a beneficial salt of a luteinizing hormone releasing hormone (LHRH) analogue formed with a strong acid that minimizes or prevents the interaction/reaction between the LHRH and the polymer in an organic solution; b) a biodegradable polymer; c) a pharmaceutically acceptable organic solvent; and d) optionally one or more excipients. The present invention also relates to a method of manufacturing and a method of use thereof.

Abstract: The display box includes a box body including an upper cover, a rotating shaft rotatably connected with the upper cover, and a support plate disposed on the upper surface of the upper cover via the rotating shaft to fix an exhibit. The support plate is rotatable with the rotating shaft to make the exhibit be at a preset angle with respect to the upper surface.

Abstract: The present invention provides a method for separating out a defect image from a thermogram sequence based on feature extraction and multi-objective optimization, we find that different kinds of TTRs have big differences in some physical quantities, such as the energy, temperature change rate during endothermic process, temperature change rate during endothermic process, average temperature, maximum temperature. The present invention extract these features (physical quantities) and cluster the selected TTRs into L clusters based on their feature vectors, which deeply digs the physical meanings contained in each TTR, makes the clustering more rational, and improves the accuracy of defect separation. Meanwhile, the present invention creates a multi-objective function to select a RTTR for each cluster based on multi-objective optimization.

Abstract: The present application provides a display box and a display device. The display box includes a box body and a first support plate detachably connected with the box body. The first support plate is one of multiple first support plates with different sizes, and the multiple first support plates are selectively detachably connected with the box body for supporting flexible screens with different bending radii.

Abstract: This invention provides compounds of formula I: wherein a, b, c, d, m, n, p, s, t, W, Ar1, R1, R2, R3, R4, R6, R7, and R8 are as defined in the specification. The compounds of formula I are muscarinic receptor antagonists. The invention also provides pharmaceutical compositions containing such compounds, processes and intermediates for preparing such compounds and methods of using such compounds to treat pulmonary disorders.

Abstract: The invention belongs to the technical field of the quantitative statistical distribution analysis of the features from characteristic images of microstructures and precipitated phases in metal materials, and relates to a quantitative statistical distribution characterization method of precipitate particles with the full field of view in a metal material. The method comprises the following steps of electrolytic corrosion of a metallic material specimen, automatic collection of characteristic images of microstructure, automatic stitching and fusion of the full-view-field microstructure images, automatic identification and segmentation of the precipitate particles and quantitative distribution characterization of the precipitate particles with the full field of view in a large-range scale.

Abstract: A method of designing a box-type energy-dissipating section of a box-type energy-dissipating mudflow diversion flume. Firstly, the longitudinal gradient J of the flume and the roughness coefficient n 0 of a fully-lined flume bottom (1) are determined. Then, the parameters of the box-type energy-dissipating section are set, and related parameters are substituted into a formula for calculation, so that the overall roughness coefficient n of the flume is obtained. Further, the flow velocity of the mudflow is calculated by means of the Manning formula. Finally, the flow velocity of the mudflow is compared with the non-scouring and non-silting velocity allowed by the flume, and the design value of the box-type energy-dissipating section is obtained through final optimization. The method factors in the longitudinal gradient J of the flume, the length L of the box-type energy-dissipating section, the width b of the box-type energy-dissipating section, and the average diameter D of filler stones.